Last updated: May 29, 2026

The General Hospital Corporation

110 pending office actions • 60 art units • 98 examiners • 0 of 110 (0%) have an AI response strategy ready • 121 patents granted in the last 365 days

Portfolio Summary

110

Total Pending OAs

Non-Final OAs

Final Rejections

Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 110 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

Overdue

Due this week

Due this month

Due in next 60 days

Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 110 of the docket's apps have a known mailing date.

Overdue (58)Due ≤ 7 days (2)Due ≤ 30 days (30)Due ≤ 60 days (11)Due later (9)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

Hard (4%)

Medium (77%)

Easy (6%)

Unknown (13%)

Rejection Statute Mix

Bucket	Cases
§101 only	4 (4%)
§103 only	74 (67%)
§102 only	10 (9%)
§112 only	7 (6%)
Double-patenting + other	1 (1%)
No statute on record	14 (13%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

Life Sciences

65% of docket

Information Tech

1% of docket

Communications

3% of docket

Semiconductors

2% of docket

Mechanical / Eng

29% of docket

Business / Other

0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,100 h

Manual time on pending OAs

220 h

Time saved (low, 20%)

385 h

Time saved (mid, 35%)

9.6 wks

FTE-weeks freed (mid)

Top Examiners on this docket

Examiner	Apps on this docket	Allow rate	Interview lift
HALVORSON, MARK	3	48.0%	+21.6%
GUSTILO, ESTELLA M	2	52.7%	+33.9%
BERHANU, ETSUB D	2	65.5%	+24.5%
KIM, YOUNG J	2	64.8%	+17.9%
POHNERT, STEVEN C	2	12.1%	+18.3%
FETTEROLF, BRANDON J	2	49.5%	+14.6%
TALTY, MARIA CHRISTINA	2	63.5%	+31.0%
PENNINGTON, KATIE LEIGH	2	27.3%	+60.6%
BEHARRY, ZANNA MARIA	2	23.3%	+54.0%
VIRK, ADIL PARTAP S	2	47.7%	+41.8%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #	Title	Examiner	Due in
17609181	METHOD TO INDUCE HEMATOPOIETIC CHIMERISM	PENNINGTON, KATIE LEIGH	99d overdue
18021625	PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF	POHNERT, STEVEN C	52d overdue
17772017	Gene Therapy Approaches to Mucolipidosis IV (MLIV)	PENNINGTON, KATIE LEIGH	51d overdue
17428593	PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS	BEHARRY, ZANNA MARIA	31d overdue
18503936	Highly Sensitive EGFRvIII Detection	KIM, YOUNG J	17d overdue
17626728	ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF	BEHARRY, ZANNA MARIA	9d overdue
17602246	GENERATING IMAGING-BASED NEUROLOGICAL STATE BIOMARKERS AND ESTIMATING CEREBROSPINAL FLUID (CSF) DYNAMICS BASED ON COUPLED NEURAL AND CSF OSCILLATIONS DURING SLEEP	VIRK, ADIL PARTAP S	5d
16969098	CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT	MARVICH, MARIA	33d

Interview Candidates (21)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #	Title	Examiner	Due in
18010695	TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM	FETTEROLF, BRANDON J	160d overdue
17089408	COMPOSITIONS AND METHODS FOR PERSONALIZED NEOPLASIA VACCINES	HALVORSON, MARK	155d overdue
17609181	METHOD TO INDUCE HEMATOPOIETIC CHIMERISM	PENNINGTON, KATIE LEIGH	99d overdue
18818268	ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME	GUSTILO, ESTELLA M	72d overdue
18021625	PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF	POHNERT, STEVEN C	52d overdue
17772017	Gene Therapy Approaches to Mucolipidosis IV (MLIV)	PENNINGTON, KATIE LEIGH	51d overdue
16293325	SYSTEM AND METHOD FOR MONITORING AND CONTROLLING A STATE OF A PATIENT DURING AND AFTER ADMINISTRATION OF ANESTHETIC COMPOUND	BERHANU, ETSUB D	51d overdue
17428593	PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS	BEHARRY, ZANNA MARIA	31d overdue

Top Art Units

Art Unit	Apps
3797	5
3798	5
1646	5
3791	4
1613	4
1632	4
1618	4
3783	4
3796	3
1636	3

Pending Office Actions

App #	Title	Examiner	Art Unit	Statutes	Status	Due in	AI	Filed
19029949	SYSTEMS AND METHODS FOR MICRO-OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE COCHLEA	KLEIN, BROOKE L	3797	Other	Non-Final OA	13d	Pending	Jan 17, 2025
18875000	SYSTEM FOR AND METHOD OF MEASURING BLOOD PRESSURE NON-INVASIVELY WITH LIGHT	JACOB, OOMMEN	3797	§103	Non-Final OA	5d overdue	Pending	Dec 13, 2024
18862300	SYSTEM FOR AND METHOD OF PLANNING AND REAL-TIME NAVIGATION FOR TRANSCRANIAL FOCUSED ULTRASOUND STIMULATION	NGUYEN, HIEN NGOC	3797	§103	Final Rejection	29d	Pending	Nov 01, 2024
18862293	SYSTEMS AND METHODS FOR ELECTROPHYSIOLOGICAL SIGNAL RECORDING AND POSITION OR MOTION MONITORING DURING MAGNETIC RESONANCE IMAGING	JASANI, ASHISH SHIRISH	3798	§102	Non-Final OA	8d	Pending	Nov 01, 2024
18856679	MATERIALS AND METHODS FOR LUMINESCENCE-BASED CARBON DIOXIDE SENSING	CELESTINE, NYROBI I	3798	§103	Non-Final OA	49d overdue	Pending	Oct 14, 2024
18848815	METHOD AND APPARATUS FOR DERMATOLOGICAL TREATMENT	MARSH, OWEN LEWIS	3796	§103	Non-Final OA	42d	Pending	Sep 19, 2024
18818268	ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME	GUSTILO, ESTELLA M	1646	Other	Non-Final OA	72d overdue	Pending	Aug 28, 2024
18840299	AUTONOMOUS LINEAR SCANNING X-RAY SYSTEM FOR SPINAL SURGERY GUIDANCE	KIKNADZE, IRAKLI	2884	§103	Non-Final OA	12d	Pending	Aug 21, 2024
18796175	SYSTEMS AND METHODS FOR HAIR TRANSPLANT	LONG, SARAH A	3771	§103	Non-Final OA	29d	Pending	Aug 06, 2024
18771884	SYSTEM AND METHOD FOR CHARACTERIZING BRAIN STATES DURING GENERAL ANESTHESIA AND SEDATION USING PHASE-AMPLITUDE MODULATION	BERHANU, ETSUB D	3791	§103	Non-Final OA	16d	Pending	Jul 12, 2024
18639238	ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF	BERKE-SCHLESSEL, DAVID W	1651	§112	Non-Final OA	26d	Pending	Apr 18, 2024
18618523	DI-CUMYL PEROXIDE CROSSLINKING OF UHMWPE	BOYLE, ROBERT C	1764	§103	Non-Final OA	15d overdue	Pending	Mar 27, 2024
18688518	METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS	RIVERA-MARTINEZ, GUILLERMO M	2677	§112	Non-Final OA	22d overdue	Pending	Mar 01, 2024
18444413	INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME	ROSENTHAL, ANDREW S	1613	§103	Non-Final OA	63d	Pending	Feb 16, 2024
18681031	MINIATURIZED MAGNETIC FIELD SENSOR	PATEL, RISHI R	2896	§103	Final Rejection	14d	Pending	Feb 02, 2024
18428820	COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT	FUBARA, BLESSING M	1613	§103	Final Rejection	17d overdue	Pending	Jan 31, 2024
18417024	INJECTABLE PROLONGED-RELEASE HYDROGEL FORMULATIONS OF TOLL-LIKE RECEPTOR AGONISTS FOR INTRATUMORAL INJECTION TO INCREASE IMMUNOTHERAPY RESPONSE	ANTHOPOLOS, PETER	1611	§102	Non-Final OA	46d	Pending	Jan 19, 2024
18415999	Increasing Specificity for RNA-Guided Genome Editing	HUDSON, AMY ROSE	1636	§103	Final Rejection	28d overdue	Pending	Jan 18, 2024
18572580	USE OF EXTENSIVELY HYDROLYSED PROTEIN	MCCLAIN, TYNESHA L.	1793	§103	Non-Final OA	21d	Pending	Dec 20, 2023
18571154	METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES	HOLCOMB, MARK	3685	§103	Non-Final OA	56d overdue	Pending	Dec 15, 2023
18511486	Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules	WANG, RUIXUE	1632	§103	Non-Final OA	75d	Pending	Nov 16, 2023
18507709	Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity	LEE, JAE W	1656	Other	Final Rejection	19d	Pending	Nov 13, 2023
18560000	Methods and Compositions for Extending Organ and Tissue Preservation	VAN BUREN, LAUREN K	1638	Other	Non-Final OA	10d overdue	Pending	Nov 09, 2023
18503936	Highly Sensitive EGFRvIII Detection	KIM, YOUNG J	1681	§101	Non-Final OA	17d overdue	Pending	Nov 07, 2023
18559016	COLLABORATIVE ARTIFICIAL INTELLIGENCE ANNOTATION PLATFORM LEVERAGING BLOCKCHAIN FOR MEDICAL IMAGING	PAULS, JOHN A	3683	§103	Final Rejection	79d overdue	Pending	Nov 03, 2023
18558001	SYSTEM AND METHOD FOR OPTICAL PRESSURE SENSING OF BODY PART	MAYNARD, JOHNATHAN A	3798	§103	Non-Final OA	66d overdue	Pending	Oct 30, 2023
18555407	PHOTOCHEMICAL TISSUE BONDING CLAMP AND IRRADIATION CHAMBER AND METHOD OF USE THEREOF	DIETRICH, JOSEPH M	3796	§103	Non-Final OA	15d overdue	Pending	Oct 13, 2023
18551349	INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING	ALEMAN, SARAH WEBB	3774	§103	Non-Final OA	8d	Pending	Sep 19, 2023
18468298	COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS	KIM, YOUNG J	1681	§103	Non-Final OA	83d	Pending	Sep 15, 2023
18279848	PERSONALIZED REDIRECTION AND REPROGRAMMING OF T CELLS FOR PRECISE TARGETING OF TUMORS	ALDARONDO, DASIA ALI	1647	Other	Non-Final OA	33d	Pending	Aug 31, 2023
18279162	COMPOUNDS FOR BRAIN IMAGING	BAEK, JONGHWAN NMN	1618	§103	Non-Final OA	83d	Pending	Aug 28, 2023
18547917	METHODS AND SYSTEMS FOR SAFE INJECTION OF DERMAL FILLER PROCEDURES	BRANDT, DAVID NELSON	3783	§103	Non-Final OA	20d	Pending	Aug 25, 2023
18547969	PHOTO-ECMO APPARATUS, SYSTEMS, AND METHODS	LE, QUYNH DAO	3781	§103	Final Rejection	26d	Pending	Aug 25, 2023
18263558	Minimally Invasive Devices and Methods for Measuring Intestinal Potential Difference	BLAISE, BRADFORD CHRISTOPHER	3794	§103	Non-Final OA	58d overdue	Pending	Jul 31, 2023
18274641	FC-ENHANCED ANTIBODIES FOR PREVENTION AND TREATMENT OF EBOLA VIRUS INFECTION	ALLEN, MICHAEL D	1671	§103	Non-Final OA	42d	Pending	Jul 27, 2023
18210992	MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES	MCANANY, JOHN D	1625	§103	Final Rejection	15d	Pending	Jun 16, 2023
18326335	ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF	CHATTIN, AMY MARIE	1643	§112	Non-Final OA	23d	Pending	May 31, 2023
18325332	Systemic Delivery of Polypeptides	KELLY, ROBERT M	1638	Other	Non-Final OA	9d	Pending	May 30, 2023
18036579	PROBES, SYSTEMS, AND METHODS FOR MAGNETIC RESONANCE PH SENSING	JONES, DAMERON LEVEST	1618	§102	Non-Final OA	26d overdue	Pending	May 11, 2023
18251878	BLOOD TRANSFER SHIELD AND METHODS OF USE	NGO, MEAGAN N	3781	§103	Final Rejection	1d overdue	Pending	May 04, 2023
18035174	THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF	PEEBLES, KATHERINE	1617	Other	Final Rejection	42d	Pending	May 03, 2023
18030427	INTRATUMORAL AND SYSTEMIC IMMUNIZATION USING FRACTIONAL DAMAGE-CREATING DEVICE WITH CHECKPOINT MOLECULES FOR CANCER THERAPY	PRICE, NATHAN R	3783	§103	Non-Final OA	27d	Pending	Apr 05, 2023
18028379	METHODS FOR EVALUATING MIS-C ASSOCIATED WITH COVID-19	RAMIREZ, ALEX	1798	§103	Non-Final OA	4d overdue	Pending	Mar 24, 2023
18178675	Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing	ARON, KIMBERLY A	1633	Other	Non-Final OA	15d	Pending	Mar 06, 2023
18024179	METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS	TRAN, DUY ANH	2674	§103	Non-Final OA	132d overdue	Pending	Mar 01, 2023
18021625	PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF	POHNERT, STEVEN C	1683	§101	Non-Final OA	52d overdue	Pending	Feb 16, 2023
18169695	HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING	STEVENS, MARK V	1613	§103	Non-Final OA	14d	Pending	Feb 15, 2023
18019720	Human XIST Antisense Oligonucleotides for X Reactivation Therapy	CHONG, KIMBERLY	1636	Other	Non-Final OA	27d	Pending	Feb 03, 2023
18010695	TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM	FETTEROLF, BRANDON J	1626	§103	Non-Final OA	160d overdue	Pending	Dec 15, 2022
18008316	SYSTEMS AND METHODS FOR NITRIC OXIDE GENERATION AND TREATMENT	RHEE, KELSEY	3785	§103	Non-Final OA	73d overdue	Pending	Dec 05, 2022
18007822	METHODS OF TREATING A CORONAVIRUS INFECTION	JOHNSON, CHRISTOPHER LINDSAY	1691	§103	Non-Final OA	3d overdue	Pending	Dec 02, 2022
18058707	CHIMERIC ANTIGEN RECEPTORS BASED ON ALTERNATIVE SIGNAL 1 DOMAINS	LUNDE, GRACE HENRY	1641	§103	Non-Final OA	52d overdue	Pending	Nov 23, 2022
17923838	Translation Blockers Repurposed for COVID-19 Therapy	ANDERSON, JAMES D	1629	§102	Non-Final OA	72d overdue	Pending	Nov 07, 2022
17971073	SYSTEMS AND METHODS FOR GUIDED INTERVENTION	TALTY, MARIA CHRISTINA	3797	§103	Final Rejection	70d	Pending	Oct 21, 2022
17996911	SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19	TOTH, KAREN E	3791	§103	Non-Final OA	190d overdue	Pending	Oct 21, 2022
17996725	SYSTEMS AND METHODS FOR INTEGRATED ELECTRIC FIELD SIMULATION AND NEURONAVIGATION FOR TRANSCRANIAL MAGNETIC STIMULATION	COX, THADDEUS B	3791	§103	Non-Final OA	53d overdue	Pending	Oct 20, 2022
17919848	Fluorinated Derivatives of Gabapentin and Methods of Use Thereof	DONOHUE, SEAN R	1618	§103	Final Rejection	29d overdue	Pending	Oct 19, 2022
17912272	TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3	FETTEROLF, BRANDON J	1626	Other	Non-Final OA	7d	Pending	Sep 16, 2022
17908810	METHODS AND SYSTEMS TO PRINT AND MATURE TISSUES OVER TIME IN A THREE-DIMENSIONAL SUPPORT MATRIX	NGUYEN, NGHI V	1653	§103	Non-Final OA	80d overdue	Pending	Sep 01, 2022
17904568	METHODS FOR DETECTING NTRK GENE FUSION USING RNA IN SITU HYBRIDIZATION	SWITZER, JULIET CAROLINE	1682	§103	Non-Final OA	31d overdue	Pending	Aug 18, 2022
17889811	Cellular Coding Constructs Providing Identification of Cellular Entities	KAUP, SAHANA S	1612	Other	Final Rejection	39d	Pending	Aug 17, 2022
17799164	MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION	GABEL, GAILENE	1678	§102	Non-Final OA	14d	Pending	Aug 11, 2022
17796925	METHODS FOR MICROWAVE SYNTHESIS OF DEGRADABLE POLYMERS FOR DRUG DELIVERY	BECKHARDT, LYNDSEY MARIE	1613	Other	Final Rejection	35d overdue	Pending	Aug 02, 2022
17861138	CRYOTHERAPY AND CRYOABLATION SYSTEMS AND METHODS FOR TREATMENT OF TISSUE	GIULIANI, THOMAS ANTHONY	3794	§103	Non-Final OA	37d overdue	Pending	Jul 08, 2022
17790535	MICROFLUIDIC SYSTEMS AND METHODS FOR LOW-SHEAR ISOLATION OF RARE CELLS FROM LARGE SAMPLE VOLUMES	HERON, VELVET ELIZABETH	1798	§103	Final Rejection	55d	Pending	Jul 01, 2022
17852663	THREE DIMENSIONAL MICROTISSUE BIOPRINTER	OCHYLSKI, RYAN M	1743	§103	Non-Final OA	3d overdue	Pending	Jun 29, 2022
17784935	ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF	WESTON, ALYSSA G	1633	§102	Final Rejection	16d overdue	Pending	Jun 13, 2022
17782369	COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES	MEJIAS, SAMANTHA LEE	1618	§103	Non-Final OA	3d overdue	Pending	Jun 03, 2022
17741166	CHIMERIC ANTIGEN RECEPTORS TARGETING CD37	EDGINGTONGIORDANO, FRANCESCA	1643	§103	Final Rejection	21d	Pending	May 10, 2022
17775471	HIGH-RESOLUTION SPATIAL AND QUANTITATIVE DNA ASSESSMENT	RAYMONDA, MATTHEW HAROLD	1684	§103	Non-Final OA	33d	Pending	May 09, 2022
17772017	Gene Therapy Approaches to Mucolipidosis IV (MLIV)	PENNINGTON, KATIE LEIGH	1634	§102	Final Rejection	51d overdue	Pending	Apr 26, 2022
17764459	SYSTEM AND METHOD FOR DEEP LEARNING FOR INVERSE PROBLEMS WITHOUT TRAINING DATA	JIA, XIN	2663	§103	Non-Final OA	30d	Pending	Mar 28, 2022
17761131	CD70 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES THEREOF	BUNNER, BRIDGET E	1647	§112	Final Rejection	16d	Pending	Mar 16, 2022
17689117	METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY	LYONS, MARY M	1645	§102	Final Rejection	14d	Pending	Mar 08, 2022
17638543	Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned tumor Array Devices	KWAK, DEAN P	1798	§103	Final Rejection	8d overdue	Pending	Feb 25, 2022
17636272	SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION	VASSELL, MEREDITH ABBOTT	1687	§103	Non-Final OA	85d overdue	Pending	Feb 17, 2022
17673741	OPTICAL COUPLER FOR AN ENDOSCOPE	LUU, TIMOTHY TUAN	3795	§103	Non-Final OA	15d overdue	Pending	Feb 16, 2022
17627975	SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER	LEE, YIE CHIA	1642	§103	Final Rejection	78d	Pending	Jan 18, 2022
17626728	ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF	BEHARRY, ZANNA MARIA	1632	§103	Non-Final OA	9d overdue	Pending	Jan 12, 2022
17553999	SYSTEMS AND METHODS FOR PERFUSING A HUMAN PLACENTA-BASED MRI PHANTOM	BURKE, TIONNA M	2178	§102	Non-Final OA	31d overdue	Pending	Dec 17, 2021
17619958	IMMUNE CELL SIGNATURE FOR BACTERIAL SEPSIS	IVICH, FERNANDO NMN	1678	§103	Final Rejection	81d overdue	Pending	Dec 16, 2021
17618323	AN ENZYMATIC ASSAY TO MEASURE LONG-TERM ADHERENCE TO PRE EXPOSURE PROPHYLAXIS AND ANTIRETROVIRAL THERAPY	BAUSCH, SARAE L	1699	§103	Final Rejection	34d	Pending	Dec 10, 2021
17616621	CRISPR SYSTEM HIGH THROUGHPUT DIAGNOSTIC SYSTEMS AND METHODS	POHNERT, STEVEN C	1683	Other	Non-Final OA	53d	Pending	Dec 03, 2021
17609181	METHOD TO INDUCE HEMATOPOIETIC CHIMERISM	PENNINGTON, KATIE LEIGH	1634	§103	Final Rejection	99d overdue	Pending	Nov 05, 2021
17602076	Enhancement of Melanocyte Migration Using ROCK Inhibitors	MCKILLOP, JOHN CHARLES	1637	§103	Non-Final OA	2d overdue	Pending	Oct 07, 2021
17602246	GENERATING IMAGING-BASED NEUROLOGICAL STATE BIOMARKERS AND ESTIMATING CEREBROSPINAL FLUID (CSF) DYNAMICS BASED ON COUPLED NEURAL AND CSF OSCILLATIONS DURING SLEEP	VIRK, ADIL PARTAP S	3798	§101	Non-Final OA	5d	Pending	Oct 07, 2021
17434349	TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM	OGUNBIYI, OLUWATOSIN A	1645	§103	Non-Final OA	50d overdue	Pending	Aug 26, 2021
17401623	SYSTEMS AND METHODS FOR REMOVING EXOGENOUS PARTICLES FROM THE SKIN OF A PATIENT	PATEL, SHEFALI DILIP	3783	§103	Non-Final OA	79d	Pending	Aug 13, 2021
17428593	PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS	BEHARRY, ZANNA MARIA	1632	Other	Final Rejection	31d overdue	Pending	Aug 04, 2021
17418343	ANTI-EPHRIN-B2 BLOCKING ANTIBODIES FOR THE TREATMENT OF FIBROTIC DISEASES	MELCHIOR, JAMES RYLAND	1644	§103	Final Rejection	86d overdue	Pending	Jun 25, 2021
17296829	T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses	SIFFORD, JEFFREY MARK	1671	§103	Non-Final OA	61d	Pending	May 25, 2021
17294179	CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS	GIAMMONA, FRANCESCA FILIPPA	1681	§103	Non-Final OA	3d overdue	Pending	May 14, 2021
17291588	METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS	GALSTER, SAMUEL LEONARD	1693	DPOther	Final Rejection	76d	Pending	May 05, 2021
17287349	MULTIPLEXED SINGLE-CELL ANALYSIS USING OPTICALLY-ENCODED RNA CAPTURE PARTICLES	ESPERON, NATHAN GREGORY	1799	§103	Final Rejection	12d	Pending	Apr 21, 2021
17270393	MULTIFUNCTIONAL SKIN PATCH	MULLINS, JESSICA LYNN	3792	§103	Final Rejection	43d overdue	Pending	Feb 22, 2021
17254392	CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19	GUSTILO, ESTELLA M	1646	§102	Final Rejection	19d	Pending	Dec 21, 2020
17089408	COMPOSITIONS AND METHODS FOR PERSONALIZED NEOPLASIA VACCINES	HALVORSON, MARK	1646	§103	Non-Final OA	155d overdue	Pending	Nov 04, 2020
16969098	CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT	MARVICH, MARIA	1634	§101	Final Rejection	33d	Pending	Aug 11, 2020
16944588	SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL	PATEL, SHEFALI DILIP	3783	§103	Final Rejection	72d overdue	Pending	Jul 31, 2020
16859252	SHARED NEOANTIGENS	GODDARD, LAURA B	1642	§103	Final Rejection	74d overdue	Pending	Apr 27, 2020
16858197	METHODS OF FLUID ASSESSMENT AND TREATMENT	TALTY, MARIA CHRISTINA	3797	§112	Final Rejection	30d overdue	Pending	Apr 24, 2020
16640942	METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES	DENT, ALANA HARRIS	1643	§103	Non-Final OA	87d overdue	Pending	Feb 21, 2020
16632332	COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES	STAVROU, CONSTANTINA E	1632	§103	Final Rejection	29d	Pending	Jan 17, 2020
16735146	Multiplex Guide RNAS	DACE DENITO, ALEXANDRA GERALDINE	1636	§103	Non-Final OA	97d overdue	Pending	Jan 06, 2020
16487517	METHODS OF PHOTOCHEMICAL TREATMENT FOR WOUND HEALING	SHIBUYA, MARK LANCE	1631	§103	Non-Final OA	22d	Pending	Aug 21, 2019
16528195	Compositions and Methods of Identifying Tumor Specific Neoantigens	HALVORSON, MARK	1646	§112	Final Rejection	14d	Pending	Jul 31, 2019
16349405	SYSTEMS AND METHODS FOR MULTI-DISTANCE, MULTI-WAVELENGTH DIFFUSE CORRELATION SPECTROSCOPY	VIRK, ADIL PARTAP S	3798	§103	Non-Final OA	10d overdue	Pending	May 13, 2019
16343698	SYSTEMS AND METHODS FOR THERMAL GRADIENT PRECONDITIONING FOR SELECTIVE PHOTOTHERMAL TARGETING	EISEMAN, LYNSEY C	3796	§103	Final Rejection	38d overdue	Pending	Apr 19, 2019
16293325	SYSTEM AND METHOD FOR MONITORING AND CONTROLLING A STATE OF A PATIENT DURING AND AFTER ADMINISTRATION OF ANESTHETIC COMPOUND	BERHANU, ETSUB D	3791	§103	Non-Final OA	51d overdue	Pending	Mar 05, 2019
16094786	IMPROVED HLA EPITOPE PREDICTION	HALVORSON, MARK	1646	§112	Non-Final OA	4d overdue	Pending	Oct 18, 2018

Show all 110 rows (60 more)

Managing The General Hospital Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial